Thursday - May 1, 2025

LOGIN  |  REGISTER
Cue Biopharma
Astria Therapeutics

Encompass Health opens request for grant applications

May 01, 2024 | Last Trade: US$115.94 1.05 -0.90
  • The Company will award research funding grants totaling up to $50,000.

BIRMINGHAM, Ala., May 1, 2024 /PRNewswire/ -- On May 1, Encompass Health opened its call for research grant applications due Sept. 30 at 5 p.m. CST. The grants, totaling up to $50,000, will be awarded for the investigation of the impact or effectiveness of therapies in the inpatient rehabilitation facility post-acute care setting, knowledge translation or implementation science. Grant recipients do not have to be affiliated with Encompass Health and research does not have to be conducted in an Encompass Health inpatient rehabilitation hospital.

High priority topics include:

  • Impact or effectiveness of therapies on neurological impairments
  • Efficacy of physical, occupational or speech therapy interventions
  • Prevention or control of rehabilitation-related conditions
  • Patient and caregiver education programming impact or outcomes

Applications will be evaluated based on scientific merit, experience of principal investigator(s), relevance to the grant program objectives, expected outcomes, and study feasibility. The research should be completed no more than 12 months after receiving the grant and must be conducted in the United States or Puerto Rico. Final selection of recipients and programs will be made by Oct. 30.

A copy of the application and the full details may be found at encompasshealth.com/therapy-grants.

About Encompass Health

Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 160 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

MEDIA CONTACT:
Polly Manuel | 205-970-5912
polly.manuel@encompasshealth.com

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page